🌟 Product Overview
Dienogestrel (CAS: 65928-58-7) is a synthetic progesterone receptor agonist widely used for treating endometriosis, hormonal contraception, and gynecological disorders. With the molecular formula C₂₀H₂₅NO₂ and molecular weight 311.42, it exhibits strong endometrial activity and reduces estrogen-dependent pathological growth. This high-purity compound is critical in pharmaceutical formulations, clinical therapy, and reproductive health research, offering precise hormonal regulation.
✅ Key Advantages
💊 High Purity: ≥99% HPLC-certified quality, ensuring pharmaceutical-grade performance.
🔬 Stability: Stable under ambient storage (2–25°C) with a 2-year shelf life.
📈 Clinical Efficacy: Reduces endometriosis-associated pain by 70% in clinical trials.
🧪 Structural Confirmation: Verified by NMR, MS, and chromatographic analysis.
📌 Applications
• Pharmaceuticals: Key ingredient in hormonal contraceptives and endometriosis therapies (e.g., Visanne®).
• Clinical Use: Approved for endometriosis management and uterine bleeding control.
• Research: Studied for progesterone receptor modulation and anti-inflammatory effects.
🔍 Quality Certifications
• Complies with USP/EP standards for impurities (<0.1%), residual solvents, and heavy metals.
• Batch-specific COA includes purity (≥99%), moisture (≤0.5%), and single impurity (<0.1%).
• Rigorous testing via HPLC (>98% purity), NMR, and mass spectrometry.
📈 Market Trends
The global progesterone drugs market is projected to grow at 6.8% CAGR (2025–2030), driven by rising endometriosis prevalence and demand for non-invasive hormonal therapies. Dienogestrel holds a dominant position in gynecological APIs, with expanding applications in Europe and Asia-Pacific.
China
